In the past decades, the dysregulation of AT3 has been reported to play an important role in the pathogenesis of human chronic damage diseases such as a preponderance of evidence has implicated aberrant, gastric cancer, and breast cancer [10, 13–16]. The gene discussed is ATXN3; the disease is breast cancer.